(Q42999353)

English

Combination therapy with interferon-alpha plus N-acetyl cysteine for chronic hepatitis C: a placebo controlled double-blind multicentre study

scientific article published in August 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Combination therapy with interferon-alpha plus N-acetyl cysteine for chronic hepatitis C: a placebo controlled double-blind multicentre study (English)

1 reference

Europe PubMed Central

12 November 2017

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

12 November 2017

0 references

author name string

Grant PR

1

1 reference

Europe PubMed Central

12 November 2017

Black A

2

1 reference

Europe PubMed Central

12 November 2017

Garcia N

3

1 reference

Europe PubMed Central

12 November 2017

Garson JA

5

1 reference

Europe PubMed Central

12 November 2017

publication date

1 August 2000

1 reference

Europe PubMed Central

12 November 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

12 November 2017

61

1 reference

Europe PubMed Central

12 November 2017

4

1 reference

Europe PubMed Central

12 November 2017

439-442

1 reference

Europe PubMed Central

12 November 2017

N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Time course of total cysteine, glutathione and homocysteine in plasma of patients with chronic hepatitis C treated with interferon-alpha with and without supplementation with N-acetylcysteine.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non‐A, non‐B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Glutathione deficiency and human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Anti-hepatitis B virus activity of N-acetyl-L-cysteine (NAC): new aspects of a well-established drug

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Optimisation and evaluation of a quantitative chemiluminescent polymerase chain reaction assay for hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C439%3A%3AAID-JMV5%3E3.0.CO%3B2-L

21 January 2018

Identifiers

10.1002/1096-9071(200008)61:4<439::AID-JMV5>3.0.CO;2-L

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42999353&oldid=1976324392"